Skip to content

Clinical study on the treatment of stage III - IV colorectal cancer of spleen deficiency and essence deficiency type with anticancer essence formula

Clinical study on the treatment of stage III - IV colorectal cancer of spleen deficiency and essence deficiency type with anticancer essence formula

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000037693
Enrollment
Unknown
Registered
2020-08-30
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer

Interventions

Sponsors

Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: All of the following items are met: 1. Patients with age >= 18 years and < 75 years old; 2. Patients with stage III-IV colorectal cancer confirmed by pathology (see Table 1 for staging criteria), who did not receive targeted therapy and were 1-6 months after the end of chemotherapy; 3. Patients with an estimated survival time of more than 3 months; 4. Patients who have no tumor after radical operation; 5. ECoG activity score was 0 or 1; 6. Patients with spleen deficiency and essence deficiency syndrome.

Exclusion criteria

Exclusion criteria: 1. Patients with other malignant tumor history; 2. Patients with severe cardiovascular and cerebrovascular diseases (such as stroke, myocardial infarction); 3. Patients with severe liver and kidney dysfunction (liver enzymes > 3 times of normal upper limit or estimated glomerular filtration rate < 30ml / min); 4. Patients who have received traditional Chinese medicine treatment within one month; 5. Patients who have participated in or are participating in other clinical studies within three months; 6. Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
quality of life;

Secondary

MeasureTime frame
Progression free survival;

Countries

China

Contacts

Public ContactZhu Limin

Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

zhulimin2000@126.com+86 13585534611

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026